News and events

A new formulation for the treatment and prevention of colon cancer metastases.
Start-up Imisca and Erganeo have signed an exclusive license for a new gel-forming solution to reduce recurrence rates after local treatment of colorectal cancer, improve patient survival and optimize treatment. Lire la suite Validation of a formulation from UTCBS to reduce recurrence rates after local treatment of colorectal cancer,

Formulations based on phase transition polymers or "Sol-Gel" are an important part of our research. These formulations have the particularity to be totally liquid during manufacturing and to gel during their application, thus conferring multiple advantages. This axis...

Témoignages émouvants des premiers patients traités. Les mini-plasmides pFAR (Free of Antibiotic Resistance marker), développés pour des approches de Thérapie Génique au sein de l’UTCBS par Corinne Marie (ChimieParistech, PSL) et Daniel Scherman (CNRS), sont entrés...